CENTOGENE N V's ticker is CNTG and the CUSIP is N1976T109. A total of 15 filers reported holding CENTOGENE N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,873 | -29.3% | 21,578 | 0.0% | 0.00% | – |
| Q2 2023 | $32,368 | +129.4% | 21,578 | 0.0% | 0.00% | – |
| Q1 2023 | $14,109 | -29.7% | 21,578 | 0.0% | 0.00% | – |
| Q4 2022 | $20,067 | -19.7% | 21,578 | 0.0% | 0.00% | – |
| Q3 2022 | $25,000 | -51.0% | 21,578 | 0.0% | 0.00% | – |
| Q2 2022 | $51,000 | -43.3% | 21,578 | +1.0% | 0.00% | – |
| Q1 2022 | $90,000 | -18.9% | 21,359 | -0.3% | 0.00% | – |
| Q4 2021 | $111,000 | -55.2% | 21,416 | -5.0% | 0.00% | – |
| Q3 2021 | $248,000 | +5.1% | 22,552 | 0.0% | 0.00% | – |
| Q2 2021 | $236,000 | -95.5% | 22,552 | -94.8% | 0.00% | – |
| Q1 2021 | $5,256,000 | +13.8% | 433,268 | +1.1% | 0.00% | – |
| Q4 2020 | $4,620,000 | +15.7% | 428,531 | +1.5% | 0.00% | – |
| Q3 2020 | $3,992,000 | -2.6% | 422,128 | +135.6% | 0.00% | – |
| Q2 2020 | $4,100,000 | +76.0% | 179,187 | +53.8% | 0.00% | – |
| Q1 2020 | $2,329,000 | +101.8% | 116,495 | +1.7% | 0.00% | – |
| Q4 2019 | $1,154,000 | – | 114,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 409,388 | $4,413,000 | 0.10% |
| Walleye Capital LLC | 86,582 | $933,000 | 0.06% |
| Granahan Investment Management | 154,387 | $1,664,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 200,000 | $2,156,000 | 0.02% |
| FEDERATED HERMES, INC. | 324,939 | $3,503,000 | 0.01% |
| Alyeska Investment Group, L.P. | 33,441 | $360,000 | 0.01% |
| Pentwater Capital Management LP | 16,784 | $181,000 | 0.00% |
| Squarepoint Ops LLC | 22,306 | $240,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,601 | $18,000 | 0.00% |
| Laurion Capital Management LP | 15,166 | $163,000 | 0.00% |